Answers are grounded in this paper and cite their sources.
Background Immune checkpoint inhibitors (ICIs) have transformed the prognosis in advanced melanoma. However, treatment discontinuation frequently occurs due to toxicity, durable response, or completion of adjuvant therapy. A proportion of patients subsequently experience disease relapse or progression, raising the question of whether immunotherapy resumption may restore antitumor activity. Evidence regarding the efficacy and safety of ICI rechallenge remains limited and heterogeneous. The aim of the study was to evaluate efficacy and identify prognostic factors of response to ICI resumption in patients with advanced melanoma. Methods A multicenter retrospective cohort study was conducted across three oncology centers in the Grand Est region of France. Adult patients with unresectable stage III or stage IV melanoma who received an ICI resumption after a prior ICI exposure between June 2020 and June 2025 were included. Five strategies of immunotherapy resumption were defined: rechallenge, retreatment, switch, escalation, and de-escalation. The primary outcome was objective response rate (ORR) within 12 weeks according to RECIST criteria. Results Fifty-four patients were included. The ORR within 12 weeks was 61.1% (33/54), including 27.8% complete responses (15/54) and 33.3% partial responses (18/54). No significant association was found between immunotherapy resumption strategies and ORR (p=0.18). ORR was 48.5% for monotherapy and 51.5% for combination therapy (P=0.95). Absence of intervening treatment during the treatment-free interval was independently associated with ORR (OR 3.86, 95% CI 1.16–12.86; p=0.03). Conclusion ICI resumption shows meaningful clinical activity in selected patients with advanced melanoma. These findings highlight the importance of treatment sequencing and patient selection when considering immunotherapy rechallenge.
No takes yet. Share an insight, caveat, or question.
Mathis et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: